Learning To Drive The ‘Chariot’: FDA Deputy Califf’s New Role
This article was originally published in The Tan Sheet
Executive Summary
Renowned clinical trialist and cardiologist will become deputy commissioner for medical products and tobacco, a complicated and challenging position.
You may also be interested in...
Califf's Ethics Letter Lists Conflicts He Averted
The waiting periods that followed the end of the FDA commissioner nominee’s affiliations with several pharma firms already have expired.
Califf's Ethics Letter Lists Conflicts He Averted
The waiting periods that followed the end of the FDA commissioner nominee’s affiliations with several pharma firms already have expired.
FDA Staying The Course Under Ostroff; Hamburg’s Concerns Remain Focus
Acting FDA Commissioner Ostroff says he does not envision new major priorities that would emerge in the short-term. The former FDA chief scientist is non-committal about submitting his name as a candidate for permanent commissioner.